Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-individual randomized comparison of Gadovist 1.0 versus ProHance in brain tumor MRI
2007-002888-27Phase 4Active
- Sponsor
- Knappschaft Kliniken Universitätsklinikum Bochum
- Start
- Jul 2008
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of gadobutrol and gadoteridol in primary brain neoplasm and brain neoplasm (2 arms), sponsored by Knappschaft Kliniken Universitätsklinikum Bochum. Primary endpoint: Overall assessment of contrast enhancement. Started Jul 2008; status: active.
02
Drugs
gadobutrolgadoteridol
03
Conditions
primary brain neoplasmbrain neoplasm
Beyond the preview
Go deeper on 2007-002888-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002888-27.